• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGBIM
Globeimmune Inc
10.0
0.0x
---
United StatesSTMM
Stemcell Holdings Inc
1.6M
750.0x
---
United StatesPTPI
Petros Pharmaceuticals Inc
2.6M
-0.1x
---
United StatesATHXQ
Athersys Inc
60.0
0.0x
---
United StatesISCO
International Stem Cell Corp
960.5K
-1.8x
---
United StatesRDHL
Redhill Biopharma Ltd
8.6M
0.0x
---
As of 2024-11-22

Company Information

GlobeImmune Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company’s Tarmogen platform activates the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens also reduce the number and function of regulatory T cells, thus further enabling the antigen-specific cellular immune response. It has over two Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. The Company's oncology product candidates include GI-6301, GI-6207 and GI-4000. The Company's infectious disease product candidates include GS-4774, GI-19000, GI-2010 and GI-18000.

Contact Information

Headquarters
1450 Infinite DriveLOUISVILLE, CO, United States 80027
Phone
720-667-2300
Fax
302-655-5049

Executives

Independent Chairman of the Board
J. William Freytag
President, Chief Executive Officer, Director
Timothy Rodell
Vice President - Finance, Treasurer, Secretary
C. Jeffrey Dekker
Independent Director
Augustine Lawlor
Independent Director
Daniel Mitchell

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.00
Revenue (TTM)
$6.2M
Shares Outstanding
5.8M
Globeimmune Inc does not pay a dividend.
Beta
---
EPS
$-0.39
Book Value
$0.52
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-33.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.